These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1458168)
21. [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances]. Prozorovskiĭ VB; Velikova VD; Pshenkina NN; Vasilenko ET Eksp Klin Farmakol; 1996; 59(1):64-7. PubMed ID: 8704639 [TBL] [Abstract][Full Text] [Related]
22. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of some cholinolytics in organophosphate intoxications. Faff J; Borkowska G; Bak W Arch Toxicol; 1976 Oct; 36(2):139-46. PubMed ID: 1036888 [TBL] [Abstract][Full Text] [Related]
24. [The role of M-cholinoreceptor subtypes in heart rhythm disturbances of various etiology]. Kosmachev AB; Fil'ko OA; Petrov VV Eksp Klin Farmakol; 2002; 65(1):34-6. PubMed ID: 12025782 [TBL] [Abstract][Full Text] [Related]
25. Cardiac damage in acute organophosphate poisoning in rats: effects of atropine and pralidoxime. Kose A; Gunay N; Yildirim C; Tarakcioglu M; Sari I; Demiryurek AT Am J Emerg Med; 2009 Feb; 27(2):169-75. PubMed ID: 19371524 [TBL] [Abstract][Full Text] [Related]
26. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977 [TBL] [Abstract][Full Text] [Related]
27. [The effect of antidote preparations on the immune reactions in acute dimethyl dichlorovinyl phosphate poisoning]. Zabrodskiĭ PF Eksp Klin Farmakol; 1995; 58(2):49-51. PubMed ID: 7773092 [TBL] [Abstract][Full Text] [Related]
28. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. Bymaster FP; Heath I; Hendrix JC; Shannon HE J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390 [TBL] [Abstract][Full Text] [Related]
29. [Identification of cholinoreceptors on the soma of RPa3 and LPa3 neurons in Helix lucorum]. Pivovarov AS; Drozdova EI Neirofiziologiia; 1992; 24(1):77-86. PubMed ID: 1584310 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists. Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297 [TBL] [Abstract][Full Text] [Related]
32. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain. Pilar-Cuéllar F; Paniagua MA; Mostany R; Pérez CC; Fernández-López A J Chem Neuroanat; 2005 Oct; 30(2-3):119-28. PubMed ID: 16095872 [TBL] [Abstract][Full Text] [Related]
33. [The effect of perftoran on the resistance of mice to GABA receptor antagonists and on the antidote activity of anticonvulsant agents]. Golovko AI; Kliuntina TV; Ivanov MB; Sofronov GA; Sviderskiĭ OA; Shilov VV Eksp Klin Farmakol; 1996; 59(6):34-7. PubMed ID: 9181871 [TBL] [Abstract][Full Text] [Related]
34. [The acute effects of dimethoate on the muscarinic-receptors of rat brains and the relationship between muscarinic-receptors and cholinesterase]. Sun Y; Zhou Z; Hu Y; Chen J; Jin T Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Aug; 20(4):293-5. PubMed ID: 14694657 [TBL] [Abstract][Full Text] [Related]
35. Role of muscarinic signal transduction and CREB phosphorylation in dichlorvos-induced memory deficits in rats: an acetylcholine independent mechanism. Verma SK; Raheja G; Gill KD Toxicology; 2009 Feb; 256(3):175-82. PubMed ID: 19100812 [TBL] [Abstract][Full Text] [Related]
36. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes. Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140 [TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. Raiteri M; Leardi R; Marchi M J Pharmacol Exp Ther; 1984 Jan; 228(1):209-14. PubMed ID: 6141277 [TBL] [Abstract][Full Text] [Related]
39. Pretreating rats with parenteral ophthalmic antimuscarinic agents decreases mortality from lethal organophosphate poisoning. Bryant SM; Rhee JW; Thompson TM; Aks SE Acad Emerg Med; 2007 Apr; 14(4):370-2. PubMed ID: 17296800 [TBL] [Abstract][Full Text] [Related]
40. Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists. Niu YY; Yang LM; Deng KM; Yao JH; Zhu L; Chen CY; Zhang M; Zhou JE; Shen TX; Chen HZ; Lu Y Bioorg Med Chem Lett; 2007 Apr; 17(8):2260-6. PubMed ID: 17289384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]